|
Originally published In Press as doi:10.1074/jbc.M705725200 on November 30, 2007
J. Biol. Chem., Vol. 283, Issue 7, 4189-4199, February 15, 2008
Intracellular Interaction of Interleukin-15 with Its Receptor during Production Leads to Mutual Stabilization and Increased Bioactivity*
Cristina Bergamaschi ,
Margherita Rosati ,
Rashmi Jalah ,
Antonio Valentin ,
Viraj Kulkarni ,
Candido Alicea ,
Gen-Mu Zhang ,
Vainav Patel ,
Barbara K. Felber , and
George N. Pavlakis 1
From the
Human Retrovirus Section and the Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, NCI-Frederick, National Institutes of Health, Frederick, Maryland 21702-1201
We show that co-expression of interleukin 15 (IL-15) and IL-15 receptor (IL-15R ) in the same cell allows for the intracellular interaction of the two proteins early after translation, resulting in increased stability and secretion of both molecules as a complex. In the absence of co-expressed IL-15R , a large portion of the produced IL-15 is rapidly degraded immediately after synthesis. Co-injection into mice of IL-15 and IL-15R expression plasmids led to significantly increased levels of the cytokine in serum as well as increased biological activity of IL-15. Examination of natural killer cells and T lymphocytes in mouse organs showed a great expansion of both cell types in the lung, liver, and spleen. The presence of IL-15R also increased the number of CD44high memory cells with effector phenotype (CD44highCD62L-). Thus, mutual stabilization of IL-15 and IL-15R leads to remarkable increases in production, stability, and tissue availability of bioactive IL-15 in vivo. The in vivo data show that the most potent form of IL-15 is as part of a complex with its receptor either on the surface of the producing cells or as a soluble extracellular complex. These results explain the reason for coordinate expression of IL-15 and IL-15R in the same cell and suggest that the IL-15R is part of the active IL-15 cytokine rather than part of the receptor.
Received for publication, July 12, 2007
, and in revised form, October 29, 2007.
* This work was supported by the Intramural Research Program of the NCI, Center for Cancer Research, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, NCI-Frederick, Bldg. 535, Rm. 210, Frederick, MD 21702-1201. Tel.: 301-846-1474; Fax: 301-846-7146; E-mail: pavlakis{at}ncifcrf.gov.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J.-s. Do and B. Min
IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and {gamma}{delta} T cells in vivo
Blood,
June 18, 2009;
113(25):
6361 - 6371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Quinn, B. G. Anderson, L. Strait-Bodey, A. M. Stroud, and J. M. Argiles
Oversecretion of interleukin-15 from skeletal muscle reduces adiposity
Am J Physiol Endocrinol Metab,
January 1, 2009;
296(1):
E191 - E202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rowley, A. Monie, C.-F. Hung, and T.-C. Wu
Inhibition of Tumor Growth by NK1.1+ Cells and CD8+ T Cells Activated by IL-15 through Receptor {beta}/Common {gamma} Signaling in trans
J. Immunol.,
December 15, 2008;
181(12):
8237 - 8247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Stonier, L. J. Ma, E. F. Castillo, and K. S. Schluns
Dendritic cells drive memory CD8 T-cell homeostasis via IL-15 transpresentation
Blood,
December 1, 2008;
112(12):
4546 - 4554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Demberg, J. D. Boyer, N. Malkevich, L. J. Patterson, D. Venzon, E. L. Summers, I. Kalisz, V. S. Kalyanaraman, E. M. Lee, D. B. Weiner, et al.
Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIVmac251 Mucosal Challenge
J. Virol.,
November 1, 2008;
82(21):
10911 - 10921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Rubinstein, N. A. Lind, J. F. Purton, P. Filippou, J. A. Best, P. A. McGhee, C. D. Surh, and A. W. Goldrath
IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response
Blood,
November 1, 2008;
112(9):
3704 - 3712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Duitman, Z. Orinska, E. Bulanova, R. Paus, and S. Bulfone-Paus
How a Cytokine Is Chaperoned through the Secretory Pathway by Complexing with Its Own Receptor: Lessons from Interleukin-15 (IL-15)/IL-15 Receptor {alpha}
Mol. Cell. Biol.,
August 1, 2008;
28(15):
4851 - 4861.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|